Evidence map›Paper›PMID 39335613›Full record

ArticleBiomedicines2024

Shotgun Analysis of Gut Microbiota with Body Composition and Lipid Characteristics in Crohn's Disease.

Péter Bacsur, Tamás Resál, Bernadett Farkas, Boldizsár Jójárt, Zoltán Gyuris, Gábor Jaksa, Lajos Pintér, Bertalan Takács, Sára Pál, Attila Gácser and 9 more

Abstract read
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Obesity: An Overlooked Factor in Inflammatory Bowel Disease.International journal of molecular sciences · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Péter BacsurDepartment of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Kálvária Ave. 57, H-6725 Szeged, Hungary.ORCID 0000-0002-8534-0068
Tamás ResálDepartment of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Kálvária Ave. 57, H-6725 Szeged, Hungary.
Bernadett FarkasDepartment of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Kálvária Ave. 57, H-6725 Szeged, Hungary.ORCID 0009-0007-8816-0138
Boldizsár JójártDepartment of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Kálvária Ave. 57, H-6725 Szeged, Hungary.ORCID 0000-0002-2764-3925
Zoltán GyurisDelta Bio 2000 Ltd., H-6726 Szeged, Hungary.
Gábor JaksaDelta Bio 2000 Ltd., H-6726 Szeged, Hungary.
Lajos PintérDelta Bio 2000 Ltd., H-6726 Szeged, Hungary.
Bertalan TakácsMutagenesis and Carcinogenesis Research Group, Hungarian Centre of Excellence of Molecular Medicine, University of Szeged, H-6720 Szeged, Hungary.ORCID 0000-0003-2117-7406
Sára PálHCEMM-USZ Pathogen Fungi Research Group, H-6726 Szeged, Hungary.
Attila GácserHCEMM-USZ Pathogen Fungi Research Group, H-6726 Szeged, Hungary.
Kata Judit SzántóDepartment of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Kálvária Ave. 57, H-6725 Szeged, Hungary.ORCID 0000-0003-0749-5061
Mariann RutkaDepartment of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Kálvária Ave. 57, H-6725 Szeged, Hungary.
Renáta BorDepartment of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Kálvária Ave. 57, H-6725 Szeged, Hungary.
Anna FábiánDepartment of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Kálvária Ave. 57, H-6725 Szeged, Hungary.
Klaudia FarkasDepartment of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Kálvária Ave. 57, H-6725 Szeged, Hungary.
József MaléthDepartment of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Kálvária Ave. 57, H-6725 Szeged, Hungary.
Zoltán SzepesDepartment of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Kálvária Ave. 57, H-6725 Szeged, Hungary.
Tamás MolnárDepartment of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Kálvária Ave. 57, H-6725 Szeged, Hungary.
Anita BálintDepartment of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Kálvária Ave. 57, H-6725 Szeged, Hungary.

Funding

European Union 739593Ministry of Human Capacities BO/00598/19/5Ministry of Human Capacities UNKP-22-4 -SZTE-293Ministry of Human Capacities UNKP-22-4-SZTE-296Ministry of Human Capacities UNKP- 23-3 -SZTE-268Ministry of Human Capacities UNKP-23-3-SZTE-317National Research, Development and Innovation Office 125377National Research, Development and Innovation Office 129266National Research, Development and Innovation Office 134863National Research, Development and Innovation Office 143549University of Szeged NA
6 · The paper itself

Abstract

Alterations to intestinal microbiota are assumed to occur in the pathogenesis of inflammatory bowel disease (IBD). This study aims to analyze the association of fecal microbiota composition, body composition, and lipid characteristics in patients with Crohn's disease (CD). In our cross-sectional study, patients with CD were enrolled and blood and fecal samples were collected. Clinical and endoscopic disease activity and body composition were assessed and laboratory tests were made. Fecal bacterial composition was analyzed using the shotgun method. Microbiota alterations based on obesity, lipid parameters, and disease characteristics were analyzed. In this study, 27 patients with CD were analyzed, of which 37.0% were obese based on visceral fat area (VFA). Beta diversities were higher in non-obese patients (

Indexed as

IBDinflammationlipid metabolismmicrobiotaobesity

Identifiers

PMID39335613
PMCPMC11429102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.